Peter Jenner

22.1k total citations · 7 hit papers
230 papers, 16.3k citations indexed

About

Peter Jenner is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Peter Jenner has authored 230 papers receiving a total of 16.3k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Cellular and Molecular Neuroscience, 93 papers in Neurology and 60 papers in Molecular Biology. Recurrent topics in Peter Jenner's work include Parkinson's Disease Mechanisms and Treatments (78 papers), Neuroscience and Neuropharmacology Research (64 papers) and Neurotransmitter Receptor Influence on Behavior (48 papers). Peter Jenner is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (78 papers), Neuroscience and Neuropharmacology Research (64 papers) and Neurotransmitter Receptor Influence on Behavior (48 papers). Peter Jenner collaborates with scholars based in United Kingdom, United States and Tanzania. Peter Jenner's co-authors include C. D. Marsden, David T. Dexter, Anthony H.V. Schapira, C. Warren Olanow, Kevin St. P. McNaught, Andrew J. Lees, Bernard Testa, F. R. Wells, C. D. Marsden and Angela Clow and has published in prestigious journals such as Nature, Cell and The Lancet.

In The Last Decade

Peter Jenner

228 papers receiving 15.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oxidative stress in Parkinson's disease

2003 1.7k citations Peter Jenner profile →
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

1989 1.1k citations David T. Dexter, F. R. Wells et al. Journal of Neurochemistry profile →
Understanding cell death in parkinson's disease

1998 582 citations Peter Jenner, C. Warren Olanow profile →
Proteasomal function is impaired in substantia nigra in Parkinson's disease

2001 538 citations Kevin St. P. McNaught, Peter Jenner profile →
Parkinson disease: from pathology to molecular disease mechanisms

2013 528 citations David T. Dexter, Peter Jenner profile →
Etiology and pathogenesis of Parkinson's disease

2011 496 citations Anthony H.V. Schapira, Peter Jenner Movement Disorders profile →
Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease

2023 61 citations Valentina Leta, Peter Jenner et al. profile →

Peers

Countries citing papers authored by Peter Jenner

Since Specialization

Citations

This map shows the geographic impact of Peter Jenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Jenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Jenner more than expected).

Fields of papers citing papers by Peter Jenner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Jenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Jenner. The network helps show where Peter Jenner may publish in the future.

Co-authorship network of co-authors of Peter Jenner

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Jenner. A scholar is included among the top collaborators of Peter Jenner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Jenner. Peter Jenner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Should continuous dopaminergic stimulation be a standard of care in advanced Parkinson’s disease? 2023 ·Journal of Neural Transmission ·Zvezdan Pirtošek, Valentina Leta, Peter Jenner, Marc Vérin	6
2	The dynamics of social capital in first-year teaching teams: a comparative case study analysis 2020 ·Journal of Further and Higher Education ·(unknown), Peter Jenner, (unknown)	1
3	Can adenosine A2A receptor antagonists be used to treat cognitive impairment, depression or excessive sleepiness in Parkinson's disease? 2020 ·Parkinsonism & Related Disorders ·Peter Jenner, Akihisa Mori, Tomoyuki Kanda	26
4	Enhancing social enterprise sustainability: A value cocreation pathway 2017 ·USC Research Bank (University of the Sunshine Coast) ·Peter Jenner, David Fleischman	5
5	Parkinson’s Inside Out 2016 ·Journal of Parkinson s Disease ·Jon Stamford, D. Scheller, Peter Jenner	1
6	Pramipexole protects against rotenone toxicity: Mechanisms and implications 2002 ·UCL Discovery (University College London) ·Anthony H.V. Schapira, Muxin Gu, (unknown), (unknown), Peter Jenner	2
7	Proteasome inhibition causes nigral degeneration with inclusion bodies in rats 2002 ·Neuroreport ·Kevin St. P. McNaught, (unknown), Roger Belizaire, Ole Isacson, Peter Jenner, C. Warren Olanow	211
8	Changes in gene expression in macrophages infected with Mycobacterium tuberculosis : a combined transcriptomic and proteomic approach 2001 ·Immunology ·Silvia Ragno, Maria Romanò, Steven Howell, Darryl Pappin, Peter Jenner, M. Joseph Colston	116
9	Actions of the D 1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L -dopa-primed common marmosets 1999 ·Psychopharmacology ·R. K. B. Pearce, Michael S. Jackson, Donald R. Britton, Kazumi Shiosaki, Peter Jenner, C. D. Marsden	34
10	An immunodominant epitope from mycobacterial 65-kDa heat shock protein protects against pristane-induced arthritis. 1998 ·PubMed ·S. J. Thompson, (unknown), (unknown), Ginette R. Webb, Peter Jenner, M. Joseph Colston, C. J. Elson	34
11	Oxidative Damage to Proteins, Lipids, and DNA in Cortical Brain Regions from Patients with Dementia with Lewy Bodies 1998 ·Journal of Neurochemistry ·Leonidas Lyras, Robert Perry, E K Perry, Paul G. Ince, Andrew M. Jenner, Peter Jenner, Barry Halliwell	101
12	Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases 1998 ·Journal of the Neurological Sciences ·Muxin Gu, A Owen, (unknown), Jonathan M. Cooper, David T. Dexter, Peter Jenner, C. D. Marsden, Anthony H.V. Schapira	136
13	Oxidative Stress and Parkinson's Diseasea 1996 ·Annals of the New York Academy of Sciences ·A Owen, Anthony H.V. Schapira, Peter Jenner, C. D. Marsden	137
14	The effect of nitric oxide synthase inhibition on quinolinic acid toxicity in the rat striatum 1995 ·Neuroscience ·Grace Mackenzie, Peter Jenner, C. D. Marsden	22
15	Inhibition of α-Ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 1995 ·Neuroreport ·Kevin St. P. McNaught, Cosimo Altomare, Saverio Cellamare, Angelo Carotti, Ulrike Thull, Pierre‐Alain Carrupt, Bernard Testa, Peter Jenner, D. Marsden	36
16	INCREASED LEVELS OF LIPID HYDROPEROXIDES IN THE PARKINSONIAN SUBSTANTIA-NIGRA - AN HPLC AND ESR STUDY (VOL 9, PG 92, 1994) 1994 ·UCL Discovery (University College London) ·(unknown), (unknown), (unknown), T. F. Slater, (unknown), (unknown), AJ Lees, Peter Jenner, (unknown)	33
17	Terguride stimulates locomotor activity at 2 months but not 10 months after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets 1992 ·European Journal of Pharmacology ·Klaus W. Lange, Peter‐A. Löschmann, H. Wachtel, R. Horowski, Peter Jähnig, Peter Jenner, C. D. Marsden	13
18	A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra 1989 ·Journal of Neurochemistry ·(unknown), Jon D. Cooksey, David T. Dexter, F. R. Wells, Andrew J. Lees, Peter Jenner, C. D. Marsden	374
19	Oxyferriscorbone elevates the total iron content of blood but not brain 1989 ·Movement Disorders ·David T. Dexter, Peter Jenner, C. D. Marsden	5
20	Elevation of circulating prolactin concentrations may not cause striatal dopamine receptor supersensitivity 1983 ·European Journal of Pharmacology ·N.M.J. Rupniak, (unknown), S. Mansfield, Simon Fleminger, R.G. Dyer, Peter Jenner, C. D. Marsden	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact